Abstract

Until recently, Norway remained immovable on its conservative policy that illegal drug use is a crime. In 2018, the Health Minister appointed an inquiry commission to design a less restrictive drug policy, which included two “drug user representatives.” But the Minister’s choices for these posts met massive dissatisfaction from some drug users who contended that the representatives “are not real drug users” and do not “speak for” nor “act on the behalf” of their experiences and opinions. They mobilized to establish an alternative organization, the Shadow Committee, to propose a drug policy reform shaped by “the user voices” and “not polluted by political compromises.” Yet, while performing a labor of difference, this committee, too, became caught in conflicting landscapes of representation with some members contesting strategic solidarity. Based on this case, and an ethnographic fieldwork among the protesters, this article investigates the concept of representation as understood, contested and applied by “drug users.” Exploring how they relate to “user voices” and question the authenticity of some of “user representatives,” I highlight how changing political landscapes affect understandings of representation and shape political, individual and collective forms of involvement. I draw on Pitkin’s political philosophy and apply the classical categorization of political representation to suggest reconsidering the governing assumptions regarding “user representatives” that increasingly inform drug and treatment policies in Norway. I ask if the concept of representation itself may be a barrier to meaningful involvement.

Highlights

  • Persons using drugs are mobilizing worldwide to reject being treated as “sub-human beings” (Bijay Pandey, in Jurgens, 2005) or even “reduced to nothingness” (Bud Osborn, in Zigon, 2015, p. 509)

  • According to Minister of Health and Care Services Bent Høie: In Norway, it is a given that user organizations and other representatives of civil society should be heard before a new policy is adopted

  • I believe it is essential for Norway and the Council of Europe, which is based on the values of human rights, democracy and rule of law, to emphasize the importance of listening to those to whom this applies. (Norwegian Ministry of Health and Care Services, 2018)

Read more

Summary

Introduction

Persons using drugs are mobilizing worldwide to reject being treated as “sub-human beings” (Bijay Pandey, in Jurgens, 2005) or even “reduced to nothingness” (Bud Osborn, in Zigon, 2015, p. 509). Anker et al, 2006; Bjerge et al, 2016; Frank et al, 2012; Jurgens, 2005; Madden et al, 2021; van Dam, 2008; Willesrud & Olsen, 2006; Zigon, 2018) In response to these demands as well as general calls for democratizing expertise and policy making, national and global authorities are increasingly including “lay experts,” “service users” and “those to whom it applies” in the development of policies, strategies, plans and regulations. According to Minister of Health and Care Services Bent Høie: In Norway, it is a given that user organizations and other representatives of civil society should be heard before a new policy is adopted. They have a key role in the drug policy debate. I believe it is essential for Norway and the Council of Europe, which is based on the values of human rights, democracy and rule of law, to emphasize the importance of listening to those to whom this applies. (Norwegian Ministry of Health and Care Services, 2018)

Objectives
Methods
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.